In the news

Jodi Eddy, chief information and digital officer at Boston Scientific, explains the link between broadband access and telehealth access—and the subsequent impact on healthcare disparities.

Boston Scientific’s tumor-targeting glass microbeads continue to shatter expectations for cancer treatment. The latest results of a long-term study showed adding TheraSpheres to a standard chemotherapy regimen could extend survival for patients with colorectal cancer that has spread to the liver.

CAUTION: In the U.S., the use of TheraSphere for mCRC is for investigational use only as the safety and effectiveness have not been established.

As the University of Minnesota launches the Center for Medical Device Cybersecurity, KSTP reports how Boston Scientific is one of five Minnesota device companies that have provided funding.

Boston Scientific Chief Digital Health Officer David Feygin shares his career journey and leadership tips with professionals on the Ivy Podcast.

Boston Scientific recently announced FDA clearance of the EXALT Model B single-use bronchoscope, intended for bedside procedures in intensive care units or in the operating room. Medgadget had the opportunity to speak with Dave Pierce, Executive Vice President and President, MedSurg and President, Endoscopy, at Boston Scientific, about the new bronchoscope.